MedPath

STrong Relationships to Improve DiabEtes Pilot

Not Applicable
Not yet recruiting
Conditions
Type 2 Diabetes
Registration Number
NCT07210593
Lead Sponsor
Vanderbilt University Medical Center
Brief Summary

This is a pilot and feasibility study for a mobile phone-delivered intervention, called STRIDE (STrong Relationships to Improve DiabEtes), designed to provide support for adults with type 2 diabetes (improve glycemic management and social support). The goal of the study is to examine the feasibility and acceptability of STRIDE.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
180
Inclusion Criteria

PERSONS WITH DIABETES:

  • Speaks and reads in English
  • 18-75 years old
  • Diagnosed with type 2 diabetes
  • Receiving outpatient care from a partnering clinic
  • Community-dwelling (e.g., not in a nursing facility)
  • Prescribed at least one daily diabetes medication
  • Owns a mobile phone
  • Elevated diabetes distress or low diabetes self-efficacy
  • Willing to invite a close friend or family member to co-participate

SUPPORT PERSONS:

  • Speaks and reads in English
  • 18 years or older
  • Owns a mobile phone
Exclusion Criteria

PERSONS WITH DIABETES

  • Unable to communicate by phone
  • Currently pregnant
  • Currently undergoing treatment for cancer (e.g., radiation, chemotherapy)
  • Diagnosed with end-stage renal disease
  • Receiving hospice services
  • Diagnosed with congestive heart failure
  • Diagnosed with dementia
  • Diagnosed with schizophrenia
  • Demonstrated an inability to receive and respond to a text
  • Does not take medication on his/her own/medication administered by someone else SUPPORT PERSONS
  • Demonstrated inability to receive & respond to a text
  • Unable to communicate by phone

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Acceptability6 months post-baseline

Net Promoter Score with scores ranging 0 to 100 where higher scores (scaled score \>0) indicate good acceptability

Feasibility (Recruitment)baseline

Proportion of eligible screens who enroll

Feasibility (Treatment Adherence)6 months post-baseline

Proportion of interactive texts with response

Feasibility (Assessment Completion)3 and 6 months post-baseline

Proportion of self-report measures completed

Secondary Outcome Measures
NameTimeMethod
Change in Hemoglobin A1cBaseline and 3 and 6 months post-baseline

Hemoglobin A1c assessed by mail-in A1c kits from BioQuintex and/or taken from electronic health record (venipuncture or point-of-care) where higher values indicate worse glycemic management

Change in Diabetes DistressBaseline and 3 and 6 months post-baseline

Assessed by the Problem Areas in Diabetes (PAID-5) with scores ranging 0-100 where higher scores indicate more emotional, psychological and social distress related to diabetes management (worse)

Change in Psychosocial Well-beingBaseline and 3 and 6 months post-baseline

Assessed by the World Health Organization - Five Well-Being Index (WHO-5) with scores ranging 0 to 100 where higher scores indicate more well-being (better)

Change in Social Support for DiabetesBaseline and 3 and 6 months post-baseline

Assessed by the Diabetes Support Scale (DSS) with scores ranging 12 to 84 where higher scores indicate more social support for diabetes (better)

Trial Locations

Locations (1)

Vanderbilt University Medical Center

🇺🇸

Nashville, Tennessee, United States

Vanderbilt University Medical Center
🇺🇸Nashville, Tennessee, United States
McKenzie K Roddy, PhD
Contact
STRIDE@vumc.org

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.